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Suppressor of cytokine signaling-3 (Socs-3) negatively regulates theactionof variouscytokines, aswell as themetabolic hor-
mones leptin and insulin.Micewith haploinsufficiency of Socs-3, or thosewith neuronal deletion of Socs-3, are lean andmore
leptin and insulin sensitive. To examine the role of Socs-3within specific neurons critical to energy balance, we createdmice
with selective deletion of Socs-3 within pro-opiomelanocortin (POMC)-expressing cells. These mice had enhanced leptin
sensitivity, measured by weight loss and food intake after leptin infusion. On chow diet, glucose homeostasis was improved
despite normal weight gain. On a high-fat diet, the rate of weight gain was reduced, due to increased energy expenditure
rather than decreased food intake; glucose homeostasis and insulin sensitivity were substantially improved. These studies
demonstrate that Socs-3 within POMC neurons regulates leptin sensitivity and glucose homeostasis, and plays a key role
in linking high-fat diet to disordered metabolism.Introduction
Leptin is an adipocyte-derived hormone whose actions are re-
quired for normal energy homeostasis (Flier, 2004; Friedman,
2000; Zhang et al., 1994). This is best illustrated by loss of func-
tion mutations in genes encoding leptin or the leptin receptor,
which result in severe obesity in both rodents and humans
(Chenet al., 1996;Chuaet al., 1996;Clement et al., 1998; Farooqi
et al., 2002; Montague et al., 1997; Zhang et al., 1994). In com-
mon forms of human obesity and acquired obesity in rodents
secondary to ingestion of high-fat diets, leptin levels are in-
creased and the response to exogenous leptin is reduced, re-
flecting a leptin resistant state in the absence of identified muta-
tions (Considine et al., 1996; Frederich et al., 1995; Heymsfield
et al., 1999). The mechanism for such leptin resistance has
been explored in mice with high-fat diet-induced obesity (DIO),
and reduction in the ability of exogenous leptin to activate leptin
signaling in the hypothalamus after such diets has been ob-
served (El-Haschimi et al., 2000). Two key questions in the field
include identification of the molecular mechanism for the defect
in leptin signaling, and the precise siteswhere this altered signal-
ing occurs.
Leptin exerts its effects on body weight primarily through acti-
vation of the long formof the leptin receptor, and subsequent ac-
tivationof the JAK-STAT3pathway in specifichypothalamic neu-
rons (Elmquist et al., 1997; Myers, 2004; Vaisse et al., 1996).
Previous studies in our laboratory identifiedSocs-3 as apotential
mediator of central leptin resistance (Bjorbaek et al., 1998) and
subsequent experiments with Socs-3 haploinsufficient mice
confirmed this, as thesemice displayed attenuated diet-induced
obesity and an improvement in both leptin and insulin sensitivityCELL METABOLISM 4, 123–132, AUGUST 2006 ª2006 ELSEVIER INC.(Howard et al., 2004). Further, studies usingmice lacking Socs-3
selectively in neurons showed that diet-induced obesity, as well
as leptin and insulin sensitivity are importantly influenced by the
level of neuronal Socs-3 expression (Mori et al., 2004). Although
these studies clearly demonstrate that Socs-3 in general and
neuronal Socs-3 in particular plays a major role in the capacity
to develop leptin resistance, the identity of specific neurons
that contribute to Socs-3 mediated leptin resistance remains
unknown.
Leptin receptors are widely expressed in hypothalamic and
extra-hypothalamic sites (Cheung et al., 1997; Elmquist et al.,
1998; Fei et al., 1997; Mercer et al., 1996; Schwartz et al.,
1996). However, the arcuate nucleus of the hypothalamus is
a key target of leptin. A recent study demonstrated that in DIO,
leptin resistance as assessed by reduced activation of STAT3
phosphorylation in response to leptin is disproportionately evi-
dent in the arcuate nucleus (Munzberg et al., 2004). Further,
this studydemonstrated that the inhibitor of leptin signaling, sup-
pressor of cytokine signaling-3 (Socs-3)was inducedspecifically
in this area (Munzberg et al., 2004). Within the arcuate nucleus,
leptin directly inhibits orexigenicNPYandAgRPexpressing neu-
rons and simultaneously activates anorexigenic POMC contain-
ing neurons (Cowley et al., 2001; Elias et al., 1999; Mizuno et al.,
1998; Mizuno and Mobbs, 1999; Schwartz et al., 1997; van den
Top et al., 2004). Recently, a study by Balthasar et al. (Balthasar
et al., 2004) demonstrated that deletion of leptin receptors spe-
cifically from POMC-expressing cells resulted in hyperleptine-
mia and a modest increase in fat mass, reflecting the specific
role of leptin action on these neurons. In addition, in a leptin re-
ceptor null background, re-expression of leptin receptors in the
arcuate nucleus resulted in a modest decrease in body weight,DOI 10.1016/j.cmet.2006.06.010 123
A R T I C L Eand an even more striking improvement in glucose homeostasis
(Coppari et al., 2005).
Taken together, these observations support an important role
for leptin signaling in the arcuate nucleus, and POMC neurons in
particular, in energy homeostasis and metabolic regulation.
Given this fact, and the evidence that Socs-3 is a molecular me-
diator of leptin resistance, we wondered to what extent expres-
sion of Socs-3 in POMC neurons was required for setting the
level of leptin sensitivity as well as sensitivity to high-fat diet-
induced obesity and altered glucose homeostasis. To that
end, we created mice specifically lacking Socs-3 in POMC ex-
pressing cells by crossing animals expressing Cre recombinase
under control of the POMCpromoter (Balthasar et al., 2004) with
mice in which the Socs-3 gene is flanked by LoxP sites (Mori
et al., 2004; Yasukawa et al., 2003).
Results
Generation of mice lacking Socs3 in POMC-expressing
cells
To generate mice lacking Socs-3 in POMC expressing cells, we
crossed mice expressing Cre recombinase under control of the
POMC promoter (POMC-Cre) to mice with both alleles of
Socs-3 flanked by LoxP sites (Socs-3lox/lox). To verify that
Socs-3 was deleted from POMC neurons in the hypothalamus,
we performed double in situ hybridization on brains fromanimals
acutely treated with leptin, using a digoxigenin labeled POMC
probe and a 35S labeled Socs-3 probe. The ability of leptin to
stimulate Socs-3 mRNA in POMC neurons has been described
previously (Elias et al., 1999). In leptin-treated Socs-3lox/lox;
POMC-Cre animals there was a clear reduction in the number
of neurons in which Socs-3 transcript was coexpressed with
POMC transcript (Figures 1A and 1B). As seen in previous stud-
ies (Balthasar et al., 2004), a high percentage of POMC neurons
responded in the Socs-3lox/lox mice to leptin treatment. Approx-
imately, 56% of POMC cells displayed leptin-induced Socs-3
mRNA in the Socs-3lox/lox mice when stringent criteria for coex-
pression were employed (5X background) (Figure 1C). In the
Socs-3lox/lox; POMC-Cre mice however leptin-induced Socs-3
mRNA was found in only 4.7% of the population (Figure 1C).
These findings demonstrate that the mice selectively lack
Socs-3 transcript in POMC neurons. To verify that Socs-3
mRNA levels were not altered in other tissues, we examined
the level of Socs-3 mRNA in liver and pituitary and found no dif-
ference in levels between the two genotypes (Figure 6F and data
not shown).
Mice lacking Socs3 in POMC-expressing cells are more
sensitive to leptin
As previous studies from our laboratory and others have shown
(Bjorbaek et al., 1998, 2000), Socs-3 is a negative regulator of
leptin signaling. To test whether reduced Socs-3 expression in
POMC-expressing cells results in increased sensitivity to exog-
enous leptin in vivo, we implanted minipumps containing a low
dose of leptin into Socs-3lox/lox; POMC-Cre mice (n = 6) and
Socs-3lox/lox littermates (n = 7). Although all animals lost weight
in response to the surgery, the Socs-3lox/lox; POMC-Cre animals
demonstrated greater weight loss over time compared to the
Socs-3lox/lox animals (Figure 2A). Further, food intake was signif-
icantly decreased over the 14 day period in mice lacking Socs-3
in POMC-expressing cells (Figure 2B). We measured the leptin124concentration at the termination of the infusion and found that
both groups of animals had similar final leptin levels, suggesting
that the decrease in body weight and food intake was not due to
a difference in leptin concentration, but instead was due to in-
creased leptin sensitivity (Figure 2C). Indeed, terminal leptin
levels were inversely correlated with the loss in body weight in
the Socs-3lox/lox; POMC-Cre animals, a relation not observed
in the control littermates (Figure 2D). Based on the decrease in
body weight and food intake, expression of the leptin-regulated
neuropeptides AgRP, POMC, and NPY were investigated in
hypothalami upon termination of the infusion experiment
(Figure 2E). Significant genotype-specific changes were ob-
served, as POMC mRNA was increased and NPY mRNA was
Figure 1. Deletion of Socs-3 from POMC-expressing neurons
A and B) Double in situ hybridization for POMC (digoxigenin labeled, brown stain)
and Socs-3 (35S labeled, silver grains) in leptin treated Socs-3lox/lox (Socs-3 WT) (A)
and Socs-3lox/lox; POMC-Cre (Socs-3 POMC-Cre) mice (B) (n = 3).
C) Percentage of POMC labeled neurons that were positive for Socs-3. Neurons
were counted positive when the silver grain content exceeded 53 over back-
ground. *p < 0.001 by Student’s t test.CELL METABOLISM : AUGUST 2006
Role of SOCS-3 in POMC neuronsFigure 2. Socs-3lox/lox; POMC-Cre mice are more
sensitive to exogenous leptin
A) The change in body weight over 14 days in
response to implantation of a osmotic minipump
delivering 0.3 mg leptin per hour in Socs-3lox/lox
(Socs-3 WT) (n = 7) and Socs-3lox/lox; POMC-Cre
mice (Socs-3 POMC-Cre) (n = 6).
B) Total food intake (g) over 14 days.
C) Final leptin levels (ng/ml).
D) Linear regression of the body weight loss corre-
lated to terminal leptin levels.
E) Hypothalamic expression of POMC, NPY, and
AgRP, relative to total 18S RNA content.
*p < 0.05 by Student’s t test.decreased in mice lacking Socs-3 in POMC-expressing cells in
response to leptin, and correlated very well with the observation
that the Socs-3lox/lox; POMC-Cre mice had an exaggerated
decrease in food intake. There was no change in AgRP mRNA
levels. Thus, by multiple criteria, the Socs-3lox/lox; POMC-Cre
animals are more sensitive to exogenous leptin.
Mice lacking Socs3 in POMC-expressing cells have
improved glucose homeostasis on chow diet
Since mice lacking leptin receptors on POMC neurons display
a modest increase in body weight (Balthasar et al., 2004), we
compared the weights of Socs-3lox/lox (n = 9) and Socs-3lox/lox;
POMC-Cre (n = 9) animals over time while on chow diets. Inter-
estingly, although the mice lacking Socs-3 in POMC-expressing
cells aremore sensitive than controls to lowdoses of infused lep-
tin, body weight (Figure 3A) and food intake (Figure 3B) of these
animalswere not significantly different between genotypeswhile
on chowdiet. This suggests that in animals fed regular chow, the
lack of Socs-3 in POMC-expressing cells is not by itself sufficient
to alter body weight homeostasis. However, despite no change
in body weight, blood glucose levels in the Socs-3lox/lox;
POMC-Cre animals were significantly lower (Figure 3C). To fur-
ther examine whether the Socs-3lox/lox; POMC-Cre animals
have altered glucose homeostasis, a glucose tolerance test was
performed. Socs-3lox/lox; POMC-Cre animals had improved glu-
cose tolerance compared to weight and age matched littermate
controls (Figure 3D). An insulin tolerance test (ITT) demonstrated
that bothgroupswereequally sensitive to insulin (Figure3E).Glu-
cose homeostasis was improved despite finding no significant
difference in adiposity between the genotypes as measured by
fat pad weights either individually or collectively (data not
shown). Leptin levels were slightly lower in the Socs-3lox/lox;CELL METABOLISM : AUGUST 2006POMC-Cre animals in both the fed (31.6 6 6.9 versus 22.1 6
2.6) and fasted states (10.3 6 1.5 versus 7.92 6 1.6; data not
shown), although the differences were not significant. These re-
sults suggest that loss of Socs-3 expression in POMC-express-
ing cells has little or no effect on body weight under chow fed
conditions, but under these conditions Socs-3 in POMC-
expressing cells exerts effects on glucose homeostasis.
High-fat-fed mice lacking Socs3 in POMC-expressing
cells have attenuated weight gain and improved glucose
homeostasis
To determine whether Socs-3 in POMC-expressing cells plays
a greater role in energy homeostasis by contributing to leptin re-
sistance induced by high-fat diet, we next fed Socs-3lox/lox;
POMC-Cre (n = 10) and control littermates (n = 8) a high-fat,
high-sucrose diet. Previous experiments have shown that mice
placed on such a diet develop obesity, hyperleptinemia and hy-
perinsulinemia (El-Haschimi et al., 2000; Lin et al., 2000). Further,
other studies have demonstrated that in response to DIOSocs-3
expression levels in the arcuate nucleus are increased (Bjorbaek
et al., 1998; Munzberg et al., 2004). Themicewere placed on the
diet at 8 weeks of age, and a difference in the rate of increase in
body weight was evident immediately, with mice lacking Socs3
in POMC-expressing cells gaining less weight (Figure 4A). With
increasing duration of diet however, the rate of body weight in-
crease stabilized and the difference in body weight between
the two groups became insignificant. The total food intake over
the experiment did not differ between the groups, whether mea-
sured as the total amount over the experimental time frame
(Figure 4B) or on a weekly basis (data not shown). Leptin levels
were significantly decreased in the Socs-3lox/lox; POMC-Cre an-
imals on aHFD in both the fed and fasted state (Figure 4C). Since125
A R T I C L EFigure 3. Improved glucose tolerance in
Socs-3lox/lox; POMC-Cre mice
A) Body weight curves of Socs-3lox/lox (Socs-3 WT)
(n = 9) and Socs-3lox/lox; POMC-Cre mice
(Socs-3 POMC-Cre) (n = 9).
B) Total food intake over 11 weeks and terminal
blood glucose levels (26 weeks of age).
C) Blood glucose (fed state) levels at the end of the
study.
D)Glucose tolerance test at 23 weeks of age (1.5 mg
glucose/g body weight).
E) Insulin tolerance test at 22 weeks of age (1 mU
Humulin R/g body weight).
*p < 0.05 by Student’s t test.the Socs-3lox/lox; POMC-Cre mice had a reduced rate of weight
gain while on high-fat diet, yet had no alteration in feeding, the
rate of energy expenditure was determined. Over a 24 hr period,
the Socs-3lox/lox; POMC-Cre mice displayed a slight but signifi-
cant increase in VO2 and respiratory exchange ratio (RER) (Fig-
ures 4D and 4E), but no difference in the amount of heat gener-
ated was detected (Figure 4G). There also appeared to be an
increase in activity in theSocs-3lox/lox; POMC-Cremice, however
this increase was not statistically significant (Figure 4F).126To examine the effects of Socs-3 deletion from POMC-
expressing cells on glucose homeostasis we performed glucose
and insulin tolerance tests after 12 and 13 weeks on a high-fat
diet. Similar to chow-fed animals, glucose tolerance was greatly
improved in Socs-3lox/lox; POMC-Cre animals compared to con-
trol littermates (Figure 5A). Furthermore, the Socs-3lox/lox;
POMC-Cre mice also displayed a higher sensitivity to insulin in
the ITT compared to littermates (Figure 5B). As has been de-
scribed before, a high-fat diet results in an increase of bothFigure 4. Socs-3lox/lox; POMC-Cre mice have atten-
uated weight increase on a high-fat diet
A) Body weight curves of Socs-3lox/lox (Socs-3 WT)
(n = 8) and Socs-3lox/lox; POMC-Cre mice
(Socs-3 POMC-Cre) (n = 10) on a high-fat, high-
carbohydrate diet. Diet started at 8 weeks of age.
*p < 0.05 between genotypes for given week. Body
weights at week 19 are 39.1 6 2.0 and 42.8 6 1.6.
B) Total food intake over 11 weeks on a HFD.
C) Leptin levels in either the fed or fasted state.
D) Oxygen consumption averaged over a 24 hr
period.
E) Respiratory exchange ratio (VO2/VCO2) averaged
over a 24 hr period.
F) Activity averaged over a 24 hr period.
G) Average heat generated over a 24 hr period.
*p < 0.001 by Student’s t test.CELL METABOLISM : AUGUST 2006
Role of SOCS-3 in POMC neuronsFigure 5. Socs-3lox/lox; POMC-Cre mice have an
improved glucose homeostasis on HFD
A) Glucose tolerance test at 23 weeks of age
(1.5 mg glucose/g body weight) in Socs-3lox/lox
(Socs-3 WT) (n = 8) and Socs-3lox/lox; POMC-Cre
mice (Socs-3 POMC-Cre) (n = 10).
B) Insulin tolerance test at 22 weeks of age (1 mU
Humulin R/g body weight).
C) Terminal insulin levels of fed mice.
D) Correlation between fasted insulin levels and
body weights between the groups.
E) Terminal blood glucose levels in fed mice.
*p < 0.05 by Student’s t test.insulin and leptin levels. Socs-3lox/lox; POMC-Cre mice dis-
played significant lower levels of insulin in the fed state com-
pared to control littermates (Figure 5C). Further, when the insulin
levels in the fasted state were plotted in relationship to body
weight we noted a strong positive correlation between the
body weight and the levels of insulin (Figure 5D) in control
Socs-3lox/lox mice. In comparison, in the Socs-3lox/lox; POMC-
Cre mice, insulin levels did not rise as strongly with an increase
in body weight. In addition, as was seen in animals fed a regular-
chow diet, the Socs-3lox/lox; POMC-Cre animals displayed lower
blood glucose levels in the fed state (Figure 5E). These results
therefore demonstrate that expression of Socs-3 in POMC-
expressing cells plays an important role in linking high-fat diets
to changes in glucose tolerance and insulin sensitivity. Deletion
of Socs-3 from POMC-expressing cells results in increased
insulin sensitivity in the context of a high-fat diet.
Mice lacking Socs3 in POMC-expressing cells are
protected from hepatic steatosis
Exposure to high-fat diet increased the mass of all fat depots as
assessed at the termination of the experiment (when body
weights no longer differed between genotypes), and there
were no significant differences between the two genotypes in
this regard (Table 1). We also determined the total liver weight
at the termination of the study. In the littermate controls, the
HFD resulted in a significant increase of the liver weight (ex-
pressed either as grams or as percentage of BW) (data not
shown, Figure 6A) when compared to age-matched animals
that were fed a chow diet. A similar change in liver weight, pre-
dominantly the result of the formation of a fatty liver, has been
seen in other studies (Gregoire et al., 2002). The Socs-3lox/lox;
POMC-Cre mice did not display this increase in liver weight onCELL METABOLISM : AUGUST 2006HFD, and liver weight as percentage of total body weight was
also similar to age-matched mice fed a chow diet (Figure 6A).
Recent studies have shown that the enzyme SCD-1 is a crucial
regulator of the formation of fatty liver (Asilmaz et al., 2004). Fur-
ther, an increase in SCD-1 levels correlates with the develop-
ment of fatty liver in response to a high-fat diet (Biddinger
et al., 2005). Consistent with these findings, we noted an in-
crease in SCD-1 mRNA levels in HFD control mice, but no
change in SCD-1 was observed in Socs-3lox/lox; POMC-Cre
mice (Figure 6B). We also measured other genes involved in
the regulation of glucose homeostasis and fatty acid metabo-
lism and found that a similar pattern was observed for the
mRNA levels of PGC-1a, PEPCK, and Socs-3 (Figures 6C, 6E,
and 6F). We did not find a change in the regulation of SREBP-1
(Figure 6D). These results suggests that POMC-expressing cells
have the capacity to influence the formation of a fatty liver in
response to high-fat diets, and expression of Socs-3 in these
cells is a major regulator of this circuit.
Discussion
Socs-3 is a leptin inducible inhibitor of leptin signaling in vitro
and in vivo. Its expression is notably increased in the arcuate nu-
cleus in response to leptin and HFD, and deletion of just one
Socs-3 allele results in haploinsufficiency, accompanied by in-
creased leptin sensitivity and resistance to HFD (Bjorbaek
et al., 1998; Howard et al., 2004;Munzberg et al., 2004). A similar
phenotype is seen when Socs-3 is deleted selectively in neu-
rons, but the role played by Socs-3 in specific neurons involved
in regulation of energy balance and metabolism is as yet
unknown (Mori et al., 2004).127
A R T I C L EIn these experiments, we demonstrate that the ability of
Socs-3 to regulate in vivo leptin sensitive energy balance is me-
diated in part via Socs-3 within POMC neurons. Socs-3lox/lox;
POMC-Cre animals were more sensitive to low dose exogenous
leptin with respect to body weight, food intake, and neuropep-
tide expression, and had lower leptin levels when placed on
a high-fat diet. Further, loss of Socs-3 in POMC-expressing cells
reduced the rate of weight gain in response to a high-fat diet, al-
though the degree of protection against DIO in Socs-3lox/lox;
POMC-Cre mice was less than that observed in Socs-3 haploin-
sufficient animals or mice in which Socs-3 was removed from all
neurons (Howard et al., 2004; Mori et al., 2004). One factor to be
considered with our animal cohorts was the fact that they were
on amixed genetic background, with approximately even contri-
butions from C57BL/6, FVB and BALB/C inbred mouse lines.
Certain strains are more sensitive to HFD and this mixed back-
ground likely resulted in a greater variation in the weight gain.
Nonetheless, the Socs-3lox/lox; POMC-Cre had reduced rates
of body weight gain during the course of HFD, though the differ-
encebecame insignificant by the endof the study. A recent study
demonstrated that Socs-3 levels were significantly upregulated
Table 1. Individual fat pad weights after 18 weeks on HFD
Adipose tissue depot Socs-3lox/lox Socs-3lox/lox; POMC-Cre
perirenal plus retroperitoneal 0.960 6 0.1 1.09 6 0.1
perigonadal 1.97 6 0.2 2.25 6 0.2
mesenteric 1.47 6 0.1 1.16 6 0.1
subcutaneous 3.06 6 0.3 2.58 6 0.2
brown 0.45 6 0.05 0.50 6 0.05
At the termination of the HFD study, individual fat pads were carefully dissected
and weighed. After analysis, there were no significant differences in fat pad weight
between any of the groups when tested by Student’s t test.128specifically in the arcuate nucleus as early as 4 weeks on a
HFD (Munzberg et al., 2004). This is in contrast to another sug-
gested inhibitor of leptin signaling, PTP-1B, expression of which
is not upregulated with HFD. Therefore, the decreased rate of
body weight gain in the Socs-3lox/lox; POMC-Cremice in the ear-
lierweeks is likely explainedby lackof Socs-3andenhanced lep-
tin signaling in POMC-expressing cells. However, as the rate of
body weight gain between the two genotypes became more
similar in the later weeks on a HFD, factors apart from Socs-3
in the POMC neuron, such as Socs-3 in other locations or PTP-
1B, likely contribute more importantly to the regulation of body
weight in this period. Also, Socs-3 deletion from all neurons re-
sulted in a greater body weight decrease in response to a HFD
(Mori et al., 2004), suggesting that Socs-3 also regulates energy
balance in neurons apart fromPOMCneurons. This is consistent
with data suggesting that leptin regulates body weight through
actions in multiple sites (Balthasar et al., 2004; Boston et al.,
1997; Coppari et al., 2005; Grill et al., 2002).
Although Socs-3 in POMC neurons influences energy balance
in response to leptin and high-fat diet, Socs-3 in POMC neurons
has an even greater influence over glucose metabolism. Re-
moval of Socs-3 fromPOMC-expressing cells resulted in greatly
improved glucose homeostasis when animals were placed on
a high-fat diet. While it is possible that this improvement in glu-
cose homeostasis is in part due to the decreased rate of body
weight gain in the earlierweeks, several other possibilities should
be considered. First, in mice fed normal chow at a relatively
young age (7 and 9 weeks), glucose levels were consistently
lower inSocs-3lox/lox;POMC-Cremice (datanotshown), afinding
that was consistent over the course of the study. Second, blood
glucose measurements taken at the end of both chow feeding
and HFD studies demonstrated reduced glucose levels on the
Socs-3 deficient genotype. Indeed, Socs-3lox/lox; POMC-Cre
mice fed a chow diet had improved glucose tolerance,Figure 6. Socs-3lox/lox; POMC-Cre mice are pro-
tected from development of enlarged liver and have
reduced levels of SCD-1
A) Liver weight expressed as a percentage of body
weight in Socs-3lox/lox (Socs-3 WT) (n = 9) and
Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre)
(n = 9) on regular-chow diet or Socs-3lox/lox
(Socs-3 WT) (n = 8) and Socs-3lox/lox; POMC-Cre
mice (Socs-3 POMC-Cre) (n = 10) on a HFD.
B–F) Gene expression analysis using real-time PCR
of SCD-1 (B), PGC-1a (C), SREBP-1 (D), PEPCK
(E), and Socs-3 (F).
*p < 0.05 by Student’s t test.CELL METABOLISM : AUGUST 2006
Role of SOCS-3 in POMC neuronssuggesting that even under these conditions of unaltered body
weight and food intake, the lack of Socs-3 in POMC-expressing
cells results in improved glucose tolerance. Whether this im-
provement in peripheral metabolism due to lack of Socs-3 in
POMC-expressing cells is due to increased leptin signaling in
POMC neurons, or to changes in other Socs-3 regulated path-
ways in POMC-expressing cells cannot be determined by these
studies. In this regard, Socs-3 hasbeen implicatedquite strongly
asa factor that can suppress insulin signaling in several cell types
(Senn et al., 2003; Shi et al., 2004; Ueki et al., 2004). Recent stud-
ies suggest that insulin action on central pathways can exert
potent effect upon peripheral glucose metabolism including he-
patic glucose production (Obici et al., 2001, 2002). It is therefore
possible that enhanced insulin signaling in POMCneurons by re-
moval of Socs-3 results in a lower hepatic glucose production,
which could produce an improved GTT. It is also possible that
enhanced glucose metabolism in mice lacking Socs-3 in
POMC neurons is due to neuronal actions of leptin (Pocai
et al., 2005). This is consistent with recent data demonstrating
that restoration of leptin receptors in the arcuate nucleus signif-
icantly reduces blood glucose levels in leptin receptor null ani-
mals with only a modest decrease in body weight (Coppari
et al., 2005).
Several studies have provided data that the central melano-
cortin system can regulate glucose homeostasis independent
of body weight changes (Mizuno et al., 2003; Obici et al.,
2001). In leptin-deficient mice (ob/ob), transgenic overexpres-
sion of the POMC gene resulted in lower blood glucose levels,
improved glucose tolerance and lowered the weight of the liver
to the level of wild-type control animals (Mizuno et al., 2003).
These studies are in agreement with our findings, further sup-
porting the role of the POMC neuron, and POMC itself, in the
regulation of glucose homeostasis. Interestingly, in response
to a low dose of leptin, mice lacking Socs-3 in POMC cells
have higher POMC expression in the hypothalamus than control
animals, suggesting that POMC itself could be responsible for
the improved glucose homeostasis. However, removal of leptin
receptors from POMC neurons lowered levels of POMC in the
hypothalamus, yet no effect on glucose homeostasis was ob-
served in animals on a chow diet (Balthasar et al., 2004). There-
fore, it is possible that a factor within POMC neurons other than
POMC, such as CART, could play a role in regulating glucose
homeostasis. Since insulin and glucose tolerance tests are
poor means for assessing changes in hepatic glucose output,
further studies will be required to determine whether Socs-
3lox/lox; POMC-Cre mice have altered hepatic glucose produc-
tion, and/or enhanced insulin sensitivity in other peripheral tis-
sues when Socs-3 is deleted from POMC-expressing cells. It
will also be of great interest to determine whether these effects
are due to enhanced signaling in POMC neurons by leptin or
insulin, or both of these hormones.
It is of interest to note that although leptin infusion lowered
food intake to a greater extent in Socs-3lox/lox; POMC-Cre
mice, we detected no difference in food intake between the ge-
notypes fed low-fat or high-fat diets. Of course, similar food in-
take was maintained despite lower leptin levels in Socs-3lox/lox;
POMC-Cre mice, suggesting that the animals have reached
a new equilibrium in leptin sensitivity. In addition, the Socs-
3lox/lox; POMC-Cremice had a greater increase in energy expen-
diture in response to a HFD, partially compensating for the in-
crease in caloric intake on HFD. A recent study by CoppariCELL METABOLISM : AUGUST 2006et al. demonstrated that re-activation of endogenous leptin re-
ceptors specifically in the arcuate nucleus resulted in an in-
crease in locomotor activity (Coppari et al., 2005). Therefore, it
is reasonable to hypothesize that enhanced leptin action on
POMC neurons is contributing to the observed increase in en-
ergy expenditure, whether through changes in locomotor activ-
ity or through other mechanisms.
One very interesting difference between the two genotypes
was the weight of the liver. Gross anatomical comparisons be-
tween the livers of Socs-3lox/lox; POMC-Cre and control litter-
mates displayed a difference in both color and size. The total
weight of the liver of control mice was 0.75 grams higher than
the Socs-3lox/lox; POMC-Cre mice on a HFD. When the data
was expressed as percentage of body weight (to correct for
a slight increase in total body weight and body length), it be-
came evident that the livers of Socs-3lox/lox; POMC-Cre mice
on a HFD had a similar ratio of liver weight: body weight as
the mice on a chow diet. The control littermates however had
an increased ratio, a common occurrence in mice that are fed
a HFD, suggesting that enhanced leptin signaling in the
POMC neurons could protect against the development of fatty
liver. Indeed, gene expression analysis demonstrated that the
Socs-3lox/lox; POMC-Cre mice had significantly lower levels of
Stearoyl-CoA Desaturase 1 (SCD-1), PGC-1a, Socs-3 and
PEPCK in response to HFD. Previous studies have demon-
strated that increases in PGC-1a and PEPCK increase hepatic
gluconeogenesis (Sun et al., 2002; Yoon et al., 2001). For in-
stance, adenoviral-mediated overexpression of PGC-1a
in vivo in the liver resulted in higher blood glucose levels, ele-
vated insulin levels and elevated PEPCK levels (Yoon et al.,
2001). These results support our hypothesis that hepatic gluco-
neogenesis is increased in HFD, and that genetic removal of
Socs-3 from POMC-expressing cells results in an improved glu-
cose homeostasis at least in part by actions to reduce hepatic
gluconeogenesis. The exact mechanisms by which changes in
activity of POMC neurons due to Socs-3 deletion alters hepatic
gene expression remains to be investigated, although previous
studies have suggested that the melanocortin pathway is in-
volved (Mizuno et al., 2003; Obici et al., 2001). In addition, leptin
has been shown to downregulate SCD-1 through a mechanism
that involves the CNS (Asilmaz et al., 2004). Further, a genetic
cross of asebia mice, which lack functional SCD-1, and ob/ob
mice, which lack the leptin gene and have massive obesity
and fatty liver, resulted in complete reversal of the fatty liver
phenotype (Cohen et al., 2002). These observations suggest
that lower levels of Socs-3 in POMC-expressing cells enhance
leptin’s ability to suppress SCD-1 and thus prevent the forma-
tion of a fatty liver.
A major goal of current research is to use mouse genetics to
assess the role of specific molecular pathways within identified
neurons in the control of energy balance and metabolism. It is
known from prior work that POMC neurons and the signaling
modulator Socs-3 are important components of energy balance
and metabolic circuitry. Here we provide definitive genetic evi-
dence that Socs-3 modulates leptin’s ability to regulate energy
balance. In addition, Socs-3 in POMC-expressing cells is shown
to importantly modulate peripheral glucose metabolism, in part
independent of body weight or obesity. Whether these meta-
bolic consequences of Socs-3 loss in POMC-expressing cells
are due to altered signaling by leptin, insulin, or both in these
cells will be the subject of future work.129
A R T I C L EExperimental procedures
Generation of Socs-3lox/lox; POMC-Cre mice
Socs-3micewere obtained fromDr. Yoshimura and are described previously
(Yasukawa et al., 2003). Briefly, a targeting vector was constructed that con-
tained LoxP sites around the 2nd exon of the Socs-3 gene. C57BL/6 ES cells
were transfected, selected for homologous recombination and injected into
BALB/C blastocysts. Chimeras were bred with C57BL/6 mice to generate
mice heterozygotes for the conditional allele. POMC-Cre mice were de-
scribed previously (Balthasar et al., 2004). Briefly, thesemicewere generated
by inserting the Cre recombinase coding region into the ATG of the POMC
transcript using homologous recombination in bacteria and a bacterial artifi-
cial chromosome containing the POMC gene. POMC-Cre BAC DNA was
then injected into fertilized one-cell stage embryos of FVB mice. To generate
Socs-3lox/lox; POMC-Cre, mice we first crossed mice heterozygous for the
conditional Socs-3 allele (BALB/C and C57BL/6 mixed background) with
mice carrying the POMC-Cre BAC (FVB and C57BL/6 mixed background).
Subsequent crosses were performed to achieve a colony of Socs-3lox/lox
and Socs-3lox/lox; POMC-Cre mice. During breeding no mice of pure back-
ground were introduced, so the total population was on a mixed background
containing C57BL/6, BALB/C, and FVB strains. Only animals from these
crosses were used in experiments, and at all times littermates were com-
pared. All animal protocols were approved by the institutional animal care
and use committee (IACUC). Mice were housed in a temperature-controlled
environment (22C–24C) with a 14 hr light/10 hr dark cycle and provided ad
libitum water and chow (Harlan Teklad, diet 8664).
Double in situ hybridization of POMC and Socs-3 mRNA
Socs-3lox/lox (n = 3) and Socs-3lox/lox; POMC-Cre mice (n = 3) were fasted
overnight and given an intraperitoneal injection with leptin (5 mg/g body
weight; A.F. Parlow, National Hormone and Peptide Program). After 2 hr, an-
imalswere perfusedwith 10%buffered formalin (Sigma-Aldrich), sectioned at
25 mm on a microtome, and double in situ was performed for Socs-3 and
POMC as previously described (Elias et al., 1999). Silver grains were counted
on several fields of vision within the arcuate nucleus for three animals in each
group. The number of neurons containing both POMC and Socs-3 were esti-
mated by assessing the silver grains overlying POMC cells. The cells were
classified as double-labeled when the density of silver grains was at least
5-foldhigheras thebackground levels (Balthasar et al., 2004;Elias et al., 1999).
Leptin minipump study
Eighteen-week-old Socs-3lox/lox (n = 7) and Socs-3lox/lox; POMC-Cre (n = 6)
micewere anesthetizedwith isoflurane and implantedwith subcutaneous os-
motic minipumps. The reservoir allowed for a 14 day continuous delivery of
murine leptin (0.3 mg per hour). Animals were singly housed and monitored
every other day for body weight changes and food intake. Fourteen days af-
ter implantation, animals were sacrificed and blood was collected via cardiac
puncture. Hypothalami were dissected, flash-frozen in liquid nitrogen, and
stored at 280C for RNA analysis.
RNA extraction and real-time PCR
Total RNA was isolated from tissues with an RNeasy lipid tissue kit from Qia-
gen. One microgram of RNA was used for generation of cDNA using random
hexamers (Superscript, Ambion). Quantitative real-time PCR was performed
on a MX3000 Stratagene system, utilizing Taqman based probes for NPY,
AgRP and POMC peptides (Balthasar et al., 2004) and Taqman universal
PCR master mix (Applied Biosystems). Primer/probe sets for Socs-3,
PGC-1a, SREBP-1, PEPCK and SCD-1 were purchased from Applied Bio-
systems (assays on demand). All samples were analyzed as amultiplex reac-
tion measuring both the gene of interest and 18S RNA content as an internal
control. All reactions were performed in triplicate.
Insulin and glucose tolerance tests
Insulin and glucose tolerance test were performed on Socs-3lox/lox and Socs-
3lox/lox; POMC-Cre mice. For the insulin tolerance test, insulin (humulin R, Eli
Lilly) was injected intraperitoneally (1 mU/g body weight) and blood glucose
levels weremeasured through a tail-nick at 0, 15, 30, 60, and 120min. For the
glucose tolerance test, animals were injected with glucose (1.5 mg/g body
weight) and blood glucose was measured as described above.130High-fat diet studies
Socs-3lox/lox (n = 8) and Socs-3lox/lox; POMC-Cre (n = 10) mice 8weeks of age
were placed on a diet containing 58% kCal from fat and 25.5% kcal from car-
bohydrates (Research Diets, D12331). Animals were singly housed and food
intake and body weight were measured weekly. Blood glucose measure-
ments were performed at weeks 7, 9, and 18 of age. Oxygen consumption
and activity were measured at week 19 using a comprehensive lab animal
monitoring system (CLAMS, Columbia instruments). Glucose tolerance tests
were performed at week 21 and 23, and insulin tolerance was examined at
week 22. On week 25, animals were fasted overnight and blood was col-
lected from a tail-nick. At week 26, animals were sacrificed by CO2 inhala-
tion, blood was collected by cardiac puncture, and tissues were removed
and stored at -80C for further analysis. All animals were sacrificed over a 4
day timeframe between the hours of 10:00 and 12:00.
Statistical analysis
All results are expressed means6 SEM. Comparisons between groups were
tested using an unpaired Student’s t test in Graphpad Prism (Graphpad, San
Diego) or a Mann-Whitney U test when appropriate. A p value of less than
0.05 was considered to be statistically significant. Regression curves were
calculated with Microsoft Excel.
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